Burcon Nutrascience Corporation (BU.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 03-2025 | 03-2024 | 03-2023 | 03-2022 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 834 | 701 | 661 | 261 | 123 |
| Accounts receivable | 396 | -196 | -132 | 138 | -6 |
| Other Working Capital | 122 | -106 | -238 | -510 | 45 |
| Other Operating Activity | -6,865 | -6,176 | -6,306 | -5,803 | -3,195 |
| Operating Cash Flow | $-5,513 | $-5,777 | $-6,016 | $-5,914 | $-3,033 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -303 | -127 | -360 | -52 | -895 |
| Purchase Of Investment | -1,438 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | 0 | -1,217 | -1,978 |
| Other Investing Activity | 82 | 88 | -4,075 | 37 | 156 |
| Investing Cash Flow | $-1,659 | $-39 | $-4,435 | $-1,232 | $-2,717 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,215 | 1,000 | 5,000 | 0 | N/A |
| Debt Repayment | -278 | -106 | -14 | -98 | -90 |
| Common Stock Issued | 9,411 | N/A | 0 | 272 | 5,026 |
| Other Financing Activity | -122 | 7,671 | -90 | 0 | -240 |
| Financing Cash Flow | $10,225 | $8,565 | $4,896 | $174 | $4,696 |
| Exchange Rate Effect | 25 | -8 | 10 | -1 | -4 |
| Beginning Cash Position | 4,197 | 1,457 | 7,001 | 13,973 | 15,031 |
| End Cash Position | 7,276 | 4,197 | 1,457 | 7,001 | 13,973 |
| Net Cash Flow | $3,053 | $2,748 | $-5,554 | $-6,971 | $-1,054 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,513 | -5,777 | -6,016 | -5,914 | -3,033 |
| Capital Expenditure | -303 | -127 | -360 | -1,269 | -2,873 |
| Free Cash Flow | -5,816 | -5,904 | -6,375 | -7,182 | -5,906 |